| 000 | 01527 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250518100934.0 | ||
| 264 | 0 | _c20210906 | |
| 008 | 202109s 0 0 eng d | ||
| 022 | _a1876-4479 | ||
| 024 | 7 |
_a10.1093/ecco-jcc/jjaa090 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBoivineau, Lucile | |
| 245 | 0 | 0 |
_aProspective Evaluation of Cytomegalovirus Time-course Kinetics in Colonic Biopsies from Patients with Moderate-to-severe Ulcerative Colitis Following Infliximab Treatment: A Prospective Study. _h[electronic resource] |
| 260 |
_bJournal of Crohn's & colitis _cNov 2020 |
||
| 300 |
_a1644-1645 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBiopsy _xmethods |
| 650 | 0 | 4 | _aClinical Decision-Making |
| 650 | 0 | 4 |
_aColitis, Ulcerative _xdrug therapy |
| 650 | 0 | 4 |
_aColon _xpathology |
| 650 | 0 | 4 |
_aCytomegalovirus _xisolation & purification |
| 650 | 0 | 4 |
_aCytomegalovirus Infections _xdiagnosis |
| 650 | 0 | 4 |
_aFrance _xepidemiology |
| 650 | 0 | 4 |
_aGastrointestinal Agents _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInfliximab _xadministration & dosage |
| 650 | 0 | 4 | _aMedication Therapy Management |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 700 | 1 | _aLe Méhauté, Anthony | |
| 700 | 1 | _aRoblin, Xavier | |
| 773 | 0 |
_tJournal of Crohn's & colitis _gvol. 14 _gno. 11 _gp. 1644-1645 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/ecco-jcc/jjaa090 _zAvailable from publisher's website |
| 999 |
_c30909727 _d30909727 |
||